Tag: AMAL Therapeutics

Boehringer Ingelheim acquires Swiss biotech company AMAL Therapeutics

pharmanewsdaily- July 16, 2019

Boehringer Ingelheim acquisition of AMAL Therapeutics : German pharma company Boehringer Ingelheim has acquired Swiss biotech company AMAL Therapeutics for up to EUR325 million, as ... Read More